Company launches new Life Sciences website

7 September 2010

Source BioScience plc

('Source BioScience' or 'the Company')

Source BioScience launches new Life Sciences website

Source BioScience plc (LSE: SBS), the provider of expert, quality services and products to the life science research, pharma biotech and healthcare sectors, is delighted to announce the launch of its new, enhanced website encompassing its entire spectrum of life science activities - www.lifesciences.sourcebioscience.com

The new website delivers enhanced functionality to customers and, for the first time, brings the Company's complete portfolio of services and products together on a single site.

The website is the first of its kind in the industry that enables customers to order sequencing services, clones, antibodies and other research tools from one combined website. This combined offering allows customers to order everything they need from one, easy to navigate site, saving time and money. Highlights of the new website include:

·; Over 90,000 high quality antibodies accessible from a single site with enhanced search facilities

·; 16 million DNA clones coupled with our proprietary CloneHunter search engine

·; DNA sequencing ordering and information on the full suite of genomic services the Company offers including next generation sequencing

·; unique buying experience for customers under the unified brand of Source BioScience LifeSciences; modern look and completely redesigned with up to the minute content

·; single customer database compiled from previous corporate acquisitions and commercial activities

·; access to a wealth of additional information; special promotions, scientific publications and advice

Commenting on the launch of Source BioScience LifeSciences, Dr Nick Ash Managing Director, said:

"We are delighted with the launch of our new, enhanced website and online ordering platform for the life science community. We have an exceptional product and services portfolio with a breadth and depth that is possibly unique in the life science research sector. It is a great strength of our business and one we are very keen to build on.

"From a single site, the new website offers life science customers access to many of the products and services they require including sequencing, clones, antibodies and other genomic reagents and biomolecular tools. This will save our customers time, as well as money. By removing the need to shop around, we believe that we can increase cross selling and attract new customers.

"Creating a single web platform providing the functionality and flexibility that customers demand; is intuitive to navigate; fully reflecting the breadth of our offering and interfaces with all our business management systems was a significant undertaking. This was an extremely complex project and we are delighted with the outcome and I would like to thank the team behind the launch for creating and delivering such a high quality experience for our customers."

-- ENDS --

For further information, please contact:

Source BioScience Dr Nick Ash, Managing Director Tel: +44 (0) 115 973 9010[email protected]

Bishopsgate Communications Nick Rome / Gemma O'Hara Tel: + 44 (0) 207 562 3350 www.bishopsgatecommunications.com

About Source BioScience:

Source BioScience (LSE: SBS) is a highly focused healthcare and biotechnology company providing diagnostic and screening services to the healthcare community and genetic analyses and biomolecular tools and products to the life science research and pharma biotech sectors.

Its Healthcare operations provide screening and reference laboratory diagnostic testing for cancer and other diseases and additional predictive testing for treatment optimisation for clinicians and patients. Pharma Biotech Services offers support for early stage therapeutic development, offering a 'one-stop shop' from tissue pathology, immunohistochemistry, sophisticated image analysis, biomarker determination and assay development to pharmacogenomics including genotyping and gene expression analysis. The Life Sciences division provides core laboratory research support from conceptualisation to implementation, calling upon a wide range of cutting-edge technology platforms including an online catalogue of biomolecular tools. This incorporates DNA sequencing, whole genome amplification and a comprehensive library of genomic reagents and clones including cDNA and RNAi, as well as facilitating rapid access to high quality antibodies, cell cultures, diagnostic assays for cancer and other genetic testing, and related research tools.

The Group has its headquarters in Nottingham, UK where it operates state of the art reference laboratory facilities, with additional laboratory facilities in London, Cambridge, Oxford and Dublin, Ireland. Source BioScience is CPA, GLP and GCP accredited and is licensed by the Human Tissue Authority.

Further information about Source BioScience can be found at www.sourcebioscience.com